Cadila launches Parkinson's generic drug in the US market

15 Oct 2010 Evaluate

Cadila has launched generic Pramipexole tablets, used for treating Parkinson's disease, in the American market.The company's subsidiary Zydus Cadila has launched the Pramipexole tablets in the strengths of of 0.125 mg, 0.25 mg, 0.5 mg, 1 mg and 1.5 mg.

The sale of Pramipexole tablets in 2010 is estimated to be USD 632 million according to healthcare information solutions company NDC Health. Pramipexole's patent, which has expired, was held by German drugmaker Boehringer Ingelheim. Parkinson''s disease is a progressive disorder marked by muscle rigidity, weakness, shaking, tremor, and eventually difficulty in walking and talking. 

crackcrack

Zydus Lifesciences Share Price

859.10 -20.75 (-2.36%)
25-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.85
Dr. Reddys Lab 1173.55
Cipla 1525.50
Lupin 2018.35
Zydus Lifesciences 859.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...